Vivimed Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve Notice of Board Meeting
VIVIMEDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivimed Labs has notified the stock exchanges that its Board of Directors will meet on Thursday, 13 November 2025, in Hyderabad. The key agenda is to consider and approve the unaudited financial results (both standalone and consolidated) for the quarter and half year ended 30 September 2025, i.e., Q2 and H1 of FY26. The notice also includes the standard 'any other items with permission of the Chair' clause. The filing was made on 28 October 2025 under SEBI LODR Regulation 29 by Company Secretary Yugandhar Kopparthi.
This is a routine pre-results intimation and carries no direct price impact. Shareholders should watch for the actual Q2/H1 FY26 numbers when released on or shortly after 13 November, as those will drive the next directional move in the stock.